Hilleman Laboratories

Hilleman Laboratories is a biotechnology startup established in 2009 as a joint venture between Merck Sharp & Dohme Corp. (MSD), a global research-driven pharmaceutical company, and Wellcome Trust, a global charitable foundation dedicated to health. The company's mission is to develop affordable vaccines and biologics against infectious diseases that predominantly impact low- and middle-income countries. Hilleman Laboratories is making strides in this direction by establishing a first-of-its-kind vaccine and biologics development and manufacturing hub in Singapore, which includes a 30,000 square foot current Good Manufacturing Practices (cGMP) facility and a state-of-the-art research and development facility. With a solid backing from industry giants and a focus on addressing critical healthcare needs in underserved regions, Hilleman Laboratories holds promising potential for future investment opportunities.